
Journal of Organometallic Chemistry p. 281 - 287 (2017)
Update date:2022-08-17
Topics:
Govender, Preshendren
Ngubane, Siyabonga
Therrien, Bruno
Smith, Gregory S.
Two mononuclear rhodium complexes, Rh(I)-1,5-cyclooctadiene and Rh(III)-pentamethylcyclopentadienyl, and a bimetallic Rh(I)-Rh(III) mixed-valence complex were synthesised. The complexes were fully characterised using an array of analytical techniques which included NMR and infrared spectroscopy, single-crystal X-ray diffractometry, elemental analysis, and mass spectrometry. These complexes were evaluated as catalyst precursors in the hydroformylation of olefins. All catalyst precursors were active in the hydroformylation of 1-octene under optimised conditions. The rhodium complexes generally showed chemoselectivity towards the formation of linear aldehydes. The electrochemical behaviour of the rhodium complexes was examined using cyclic voltammetry.
View More
Arshine Pharmaceutical Co., Limited
website:http://www.cnarshine.com
Contact:0731-88503671
Address:Room 1109.Block C3, Lugu Enterprise Plaza,No.27 Wenxuan Road,Changsha National Hi-Tech Industrial Development Zone,Hunan ,P.R.China
Chengdu Baishixing Science and Technology Industry Co., Ltd.
website:http://www.cd-bsx.com
Contact:+86-28-88531548
Address:#217,North of Industry Road,Heshan Town,Pujiang County,Chengdu,Sichuan,China.
Chemvon Biotechnology Co. Ltd.
website:http://www.chemvon.com
Contact:86-21-58550039;86-21-31268550-8004
Address:Suite B-10#, 6999 Chuansha Road, Pudong District, Shanghai 201202, China
Changzhou LanXu Chemical Co.,ltd.(expird)
Contact:86-0519-86330911,13656129734,15261186386
Address:Room 524, Depart.Chemical, Changzhou Science and Eductaion town, Jiangsu, China;Factory: Haian Fine Chemical Industry Park,Nantong,Jiangsu,China
Contact:0512-63006287
Address:no.88.YISHENG Road,etdz-WUJIANG,SUZHOU,CHINA
Doi:10.1039/JR9540002546
()Doi:10.1002/jps.2600731226
(1984)Doi:10.1081/SCC-200026650
(2004)Doi:10.1016/j.jorganchem.2008.04.022
(2008)Doi:10.1002/chem.201801886
(2018)Doi:10.1016/j.freeradbiomed.2021.02.023
(2021)